Skip to search formSkip to main contentSkip to account menu

AL-1021

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1973
1973
A double-blind comparison of AL-1021 and chlorpromazine in hospitalized schizophrenics.
1973
1973
A double-blind comparison of AL-1021 and chlorpromazine in hospitalized schizophrenics.
1971
1971
A pilot study on the use of AL-1021 in the treatment of acute schizophrenics.
1971
1971
A pilot study on the use of AL-1021 in the treatment of acute schizophrenics.
1969
1969
A pilot study of AL-1021 in chronic schizophrenic patients.
1969
1969
Effects of a new butyrophenone compound (AL-1021) on subcortical and cortical nervous system structures in the cat.
1969
1969
A new butyrophenone derivative. AL-1021.
1969
1969
A pilot study of AL-1021 in chronic schizophrenic patients.
1969
1969
Pilot study on the use of AL-1021 in the treatment of chronic schizophrenia.
1969
1969
Pilot study on the use of AL-1021 in the treatment of chronic schizophrenia.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)